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Abstract 
Background: Milk is an important source of nutrients. The consumption of milk, however, may 
cause abdominal complaints in lactose intolerant individuals. The frequency of -13910C/C 
genotype is known to be high among Northern Russians, exceeding the prevalence in northern 
Europe. In our study we tested two hypotheses: 1) subjects with lactase non-persistent genotype 
(-13910C/C) have more gastrointestinal (GI) symptoms associated with milk 2) subjects with 
lactase non-persistence avoid using milk.   
 
Methods: In total, 518 students aged 17 to 26 years were randomly selected from different 
departments in the Northern State Medical University (NSMU) for genotyping the lactase 
activity-defining -13910C/T variant. All subjects filled in a questionnaire covering their personal 
data, self-reported GI symptoms and milk consumption habits. 
 
Results: Northern Russians consume very small amounts of milk daily. Among carriers of the 
lactase non-persistent (LNP) genotype there were 10 percentage units of milk-consumers fewer 
than among lactase-persistent (LP) subjects (p = 0.03). Complaints of GI disorders caused by 
milk were different between the genotypes (p = 0.02). Among all types of food analyzed only 
milk was associated with increased GI symptoms among subjects with the LNP genotype (OR 
=1.95, CI 1.03-3.69) 
 
Conclusions:  Subjects with -13910C/C have more GI symptoms from milk. Subjects with 
lactase non-persistent genotype avoid using milk.  In the case of increasing milk consumption 
symptoms may increase the need for medical consultation. It is thus important either for people 
themselves or for health care staff to be aware of lactase persistence/non-persistence.   
 
 
Background 
Milk is an important source of everyday nutrition. Bovine milk is a rich resource of nutrients 
containing lipids, proteins, amino acids, vitamins and minerals. Such substances as 
immunoglobulins, hormones, growth factors, cytokines, nucleotides, peptides, polyamines, 
enzymes and other bioactive peptides are also present in milk [1,2]. Milk has been considered a 
major source of calcium as well as the simplest and most “cost-effective” way to ingest calcium 
[3,4]. In that dairy products also provide other important nutrients, their consumption improves 
the nutritional quality of the diet appreciably [4,5].     
This notwithstanding, the consumption of milk has decreased over the last decade in 
Northern Europe [1,5] .  Data on milk consumption in Russia in recent years have been very 
limited and available only from market analyses, which show a decrease in milk consumption in 
some regions of country [6]. Consumption is low among young Northern Russians [7]. The 
above-mentioned properties of milk make it important for everyday nutrition, especially for 
children. Recently a national program, “School milk”, aimed to supply schoolchildren with the 
essential amount of milk daily, has been implemented in Russia [8].  
 Adult-type hypolactasia, characterized by the down-regulation of lactase enzyme activity 
in the intestine during human growth, is inherited as an autosomal recessive trait [9,10].  The 
first genetic variant associated with adult-type hypolactasia, a one-base polymorphism C>T -
13910 (rs 4988234) upstream of the lactase encoding gene on chromosome 2, was identified in 
2002[11].  This -13910 C/T is the most common variant of lactase persistence among Caucasians 
[12]. Several other population-specific variants nearby have been identified, some of them only 
suggestive [13-16]. The -13910C/T has been shown to be located in the OCT-1 binding site and 
acts as an enhancer.  Nowadays the genotyping can be used as the test for adult-type hypolactasia 
with 100% specificity in cases of unspecific abdominal complaints [17,18].  
 Milk contains disaccharide lactose, which may cause gastrointestinal problems in adults 
by reason of its poor digestion in part of population. In Northern Europe lactase persistence is 
common, which allows the majority of the population to drink milk without any consequences 
[19]. However, in populations where the frequency of the lactase persistent genotype is rather 
low the consumption of milk may cause complaints in the digestive tract [20]. The development 
of symptoms depends on the amount of milk consumed as well as on individual sensitivity. It has 
been shown that subjects with hypolactasia can tolerate moderate quantities of milk, up to 12g of 
lactose/200 ml of milk.  If the daily dose of lactose is consumed in small portions and also with a 
meal, the likelihood of symptoms is low [20,21,22]. 
 The most common gastrointestinal (GI) symptoms which characterize intolerance to 
lactose are flatulence, diarrhea, gurgling, abdominal distension and abdominal cramping 
[22,23,24].  The appearance of symptoms is clearly explained by mechanism of lactose 
utilization. Lactase-phlorizin hydrolase splits the entering lactose into two monosaccharides, 
glucose and galactose. The lack of lactase activity leads to intake of indigested lactose into the 
bowel. The osmotic effect causes diarrhea [25], while an increased level of fermentation in the 
intestine leads to increasing production of gases and thus to flatulence [26,27].   
 The prevalence of adult-type hypolactasia (lactase non-persistence, -13910C/C) among 
Northern Russians has been found to be 35% [7]. It has also been shown that the prevalence of 
the -13910C/C genotype among Russians living in the central part of the country ranges from 36 
to 50% [28,29]. This frequency is twice as high as in Finland and many times higher compared 
with other Scandinavian countries [30-33]. It also exceeds the prevalence of the -13910C/C 
genotype among Estonians [34].   
Recent studies have shown that subjects with intolerance to lactose tend to reduce their 
consumption of milk, which is predictable as far as they suffer symptoms after milk consumption 
[31,35,36,37,38]. In our previous study [7] subjects showed no differences between genotypes in 
the frequency of GI complaints during life. We found, however, that the consumption of milk is 
extremely low among the Northern Russian population compared with other Northern 
populations. Does milk consumption influence the appearance of GI symptoms in a population 
with a high frequency of the lactase non-persistent genotype but with very low consumption of 
milk on the whole?  
In the present study we sought to test two hypotheses: 1) subjects with lactase non-persistent 
genotype (-13910C/C) possibly have more gastrointestinal symptoms associated with milk 2) 
subjects with lactase non-persistence avoid using milk.   
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Methods 
Study population 
Students aged 17 to 26 years were randomly selected for this investigation from different 
departments in the Northern State Medical University (NSMU) during the period from 2006 to 
2008. Blood samples (n=241) or buccal samples (n=277) were taken from 518 subjects in total 
for the genotyping of the lactase activity-defining -13910 C/T variant.  
The first group were recruited during the period 2006-2007 and blood samples were 
drawn for the genotyping. The second group were recruited during the period 2007-2008 and 
buccal samples were taken for the same purpose. The mean age for whole group was 19.8±1.72. 
Women represented  78.2% of all participants. Both groups of students were similar with respect 
to distributions of age and gender.  
 For randomization we used the official list of students of the NSMU. Since there are 16 
faculties in the University and each has 10 to 12 groups of students we took for our study every 
third group from every fourth faculty.   
The study was approved by the Ethics Committee of the NSMU (No 08/06 from 
29.11.2006). All subjects gave their informed consent to participate. 
 
Analyses of genotype 
Blood samples were genotyped at the Department of Medical Genetics, University of Helsinki.  
Buccal samples were genotyped at the Forensic Laboratory in the University of Tampere.  
 Genotyping of blood samples was performed as previously described [11]. DNA was 
amplified by polymerase chain reaction (PCR). We used Taq polymerase (Dynazyme, 
Finnzymes, Espoo, Finland) with the conditions described elsewhere. The forward primer used 
was 5’-CCTCGTTAATACCCACTGACCTA -3’ and the reverse primer was 5’- 
GTCACTTTGATATGATGAGAGCA-3’, which cover about 400 bp regions on both sides of 
the C/T-13910 variant. The PCR product was verified by 1.5 % agarose gel electrophoresis (with 
ethidium bromide). The PCR products were purified using Shrimp Alkaline Phosphatase (USB) 
and Exonuclease I (New England Biolabs) at 37˚C for 60min and at 80˚C for 15min. 
 In sequencing, a BigDye 3.1 terminator (Applied Biosystems) was used according to the 
manufacturer’s instructions. Sequencing conditions were as follows: at 96˚C for 1min, then 25 
cycles at 96˚C for 10s, at 55˚C for 5s and at 60˚C for 4min. The sequencing reaction followed 
purification on Millipore Multiscreen plates (Millipore, USA) with Sephadex G-50 Superfine 
sepharose (Amersham Biosciences, Sweden), electrophoresis by ABI 3730 DNA Analyzer 
(Applied Biosystems) and base calling by Sequencing Analysis 5.2 software (Applied 
Biosystems). The sequence obtained was analyzed using Sequencher 4.6. software (Gene Codes, 
USA). 
 The polymorphism of lactase persistence/non-persistence SNP rs4988235 from buccal 
samples was determined by TaqMan Human Custom  Genotyping Assay from Applied 
Biosystems. The assay was performed according to the instructions provided with the assay with 
an ABI Prism 7900 HT sequence detection system (AppliedBiosystems, California, USA).  
 
Questionnaire  
All subjects gave written informed consent and filled in a questionnaire covering their personal 
data, self-reported condition of health, GI symptoms and milk consumption habits. We used the 
questionnaire with permission from Sahi [10].   
 Gastrointestinal symptoms were estimated by the question “Have you ever experienced the 
following symptoms and in what frequency?” The question was not intended to clarify the 
connection between milk consumption and symptoms. The various answers were “Every day”, 
“At least once per week”, “Every second week”, “Sometimes”.  If the participant had never had 
the symptom the item was left blank.  We classified the answer “Sometimes” together with no 
symptoms into one group and marked it “Without GI symptoms”. The second group included the 
remaining variables and was taken for analyses of differences between genotypes.  
 The influence of food on the appearance of GI disorders was estimated by the question “Do 
you have any GI disorders if you consume the following types of food?” where six types of food 
being included. Subjects were asked to put “Yes” or “No” opposite every type of food.  
 In the last part of the questionnaire subjects were asked to define their everyday milk 
product consumption from 0 to more than 5 glasses per day. The choices were “Not at all”, “1-2 
glasses”, “3-5 glasses” and “More than 5 glasses” of milk /sour milk per day. There was also an 
option to declare consumption less than 1-2 glasses per day for those who consumed milk very 
rarely.  For the analysis we classified all answers into two groups: less than daily milk 
consumption or none and daily milk consumption.   
 Comparison was made between the lactase non-persistent group (-13910C/C) and the 
lactase persistent group (-13910C/T and -13910 T/T) for all the above-mentioned questions.  
 
Statistical analysis 
The difference between genotype groups in milk consumption and others were tested by χ2 test. 
Odds ratios (OR) with 95% confidence interval (CI) for -13910C/C genotype in the logistic 
regression analysis were calculated for gastrointestinal symptoms in total and symptoms after 
several types of food, and for volume of milk/sour milk consumption. Statistical analyses were 
performed with SPSS version 15.0 (SPSS Inc. Chicago, IL, USA). 
 
 
 
 
 
 
 
 
Results 
The prevalence of the -13910C/C genotype (lactase non-persistence, LNP) among 518 young 
students from North-West Russia was found to be 35% (n = 180) while the -13910C/T genotype 
was found in 46% and -13910T/T in 19% of participants. 
About sixty percent of all subjects reported GI symptoms (Table 1). The most frequent 
symptom was stomach-ache. However, no statistically significant differences were revealed in 
the frequency of gastrointestinal symptoms in total between the LP and LNP genotype groups.  
The study brought out no statistically significant differences in symptom appearance between 
male and female participants. 
The majority of subjects consumed very small amounts of milk daily. Only about 40% of 
all participants used milk every day. Almost 50% did not use milk at all and 13% reported 
consumption of milk more seldom than daily (Table 2). Among carriers of the LNP genotype 
there were 10 percentage units fewer milk-consumers in comparison with the LP group (32.2 and 
42.0%). The differences were statistically significant (p = 0.03). Sour milk consumption did not 
show significant differences in symptoms between LP and LNP subjects.   
Milk consumption was associated with GI disorders in 13.3% of subjects with the LNP 
genotype and in 7.1% of subjects with the LP genotype (Table 3). Complaints of GI disorders 
caused by milk consumption were different between the genotypes (p = 0.02).  
Among all types of food analyzed only milk resulted in statistically significant 
differences in symptoms between LP and LNP subjects (OR =1.95, CI 1.03-3.69) (Table 4). In 
regression analysis there was no connection between consuming food and the appearance of 
symptoms except in milk consumption.  
   
 
 
 
Discussion 
Young Northern Russians consume very small amounts of milk daily.  However, among LNP 
genotype carriers there are even less milk-consumers than among LP subjects.  Our findings 
demonstrate that milk is the only type of food having an influence upon the appearance of GI 
disorders differently by genotype.  We may conclude that subjects with lactase non-persistence  
(-13910C/C) have more symptoms from milk. Subjects with lactase non-persistent genotype 
avoid using milk.   
Sour milk consumption brought out no differences between the genotypes. This is in 
accord with the previous proved finding that sour milk is better tolerated than milk by persons 
with lactose intolerance [21,39]. Sour milk contains less lactose as a result of bacterial 
fermentation.  
All students recruited for this study were considered healthy. However, only forty per 
cent of them did not report any GI symptoms and half of them reported stomach-ache, which was 
the most frequent symptom among all subjects without links to genotype. Possibly this finding 
requires further investigation of student health to clarify the causes of the frequent GI disorders 
among a healthy young population.   
Regarding other populations it was shown that only flatulence occurs significantly more 
frequently among LNP subjects [39, 40]. Jussila and associates [41] showed that loose stool was 
a more frequent symptom in subjects with selective lactose malabsorption.  
The northern Russians use very small amount of milk daily. However LNP subjects use 
less milk than people with LP genotype. Such a self-prescribed reduction is in agreement with a 
study in Finnish children with the -13910C/C genotype, who naturally diminished their usage of 
milk [31] and also with a study in children of other ethnicities [42]. It was also shown that other 
age groups also tend to reduce their milk consumption because of the appearance of symptoms 
after milk [24, 38].   
It is possible to assume that the low rate of symptoms was partly related to the low milk 
intake in our study population. It is likely even if the prevalence of adult type hypolactasia in the 
study population is as much as 35% and low milk consumption is reported symptoms appear less 
probably than in other populations. Another explanation for the low rate of symptoms may be the 
age of lactase activity down-regulation. Since there are no studies estimating the age of decline 
of enzymatic activity in Russians there is a slight possibility that this group was too young to 
demonstrate differences in GI disorders.   
Vast majority of our randomly selected students were from North-West Russia [7]. Based 
on the farming history, this area was determined in Soviet Union as milk production area.  The 
region has still been considered as one of the country’s milk and meat production areas. The 
gene-culture co-evolution between cattle milk genes and humans lactose tolerance has been 
verified for North Central Europe [43] and it seems to be also in north-western part of Russia. 
Since milk is an important source of nutrients there are numerous studies aimed to 
demonstrate the advantages and disadvantages to milk restriction or elimination from the diet. 
The lack of milk in nutrition in the young population is strongly associated with decreased bone 
mineral density and leads to osteoporosis in older age [42]. Precise statistic data of prevalence of 
osteoporosis among the Russian population are lacking. However, it is obvious that osteoporosis 
as well as a higher risk of bone fractures connected with it is an actual problem for Russia [44]. 
Building peak bone mass during childhood and adolescent can be the best means of preventing 
osteoporosis in older age.  
Conclusions 
It is surely warranted to increase milk consumption among the Russian population by 
providing a federal program. The benefits from an increase in milk consumption are obvious. At 
the same time our study has shown that lactase non-persistent subjects have higher frequency of 
GI disorders even in population with very small amount of milk consumed. It may be predicted 
that in the case of increasing milk consumption symptoms may appear more frequently and may 
increase the need for medical consultation and care. It is therefore important either for people 
themselves or for health care staff to be alert to lactase persistence/non-persistence.  
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Table 1 
The frequency of gastrointestinal symptoms (GI) among young people with lactase-
persistent/non-persistent genotype (Question “Have you ever experienced the following 
symptoms?”)  
 
Lactase non-persistence 
C/C-13910 
(n = 180) 
Lactase persistence 
C/T and T/T-13910 
(n = 338) 
 
GI symptoms n % n % p 
Stomach-ache 93 51.7 176 51.9  
Regurgitation 23 12.8 42 12.4 0.89 
Flatulence 17 9.4 38 11.2 0.65 
Heartburn 14 7.8 23 6.8 0.72 
Nausea 13 7.2 25 7.4 1.00 
Diarrhea  3 1.7 12 3.5 0.28 
Without GI 
symptoms 
74 41.1 142 42.2 0.71 
 
Table 2 
Milk consumption by genotype 
Consumption  
of milk 
Lactase non-persistence 
-13910C/C 
(n = 180) 
Lactase persistence 
-13910C/T and -13910T/T 
(n = 338) 
 n % n % 
Less than daily or none 122 67.8 196 58.0 
Daily  58 32.2 142 42.0 
Total 180 100 338 100 
 
 
 
 
 
 
 
 
 
 
 
 
 
Table 3 
The frequency of GI disorders connected to different food stuffs (Question “Do you have any GI 
disorders if you consume the following types of food?”) 
 
Type of food 
Lactase non-persistence 
-13910C/C 
(n = 180) 
Lactase persistence 
-13910C/T and -13910T/T 
(n = 338) 
 
p 
 n % n %  
Fatty 56 31.1 120 35.5 0.33 
Fried 43 23.9 69 20.4 0.37 
Milk  24 13.3 24 7.1 0.02 
Sour milk and 
kefir 16 8.9 17 5.0 0.09 
Vegetables  10 5.6 14 4.1 0.51 
Fruits 7 3.9 19 5.6 0.53 
Any other food 28 15.6 52 15.4 1.00 
Not any food 88 47.6 174 51.6 0.74 
 
 
Table 4. 
Odds ratios (OR, 95% CI) of the lactase non-persistent genotype (-13910C/C) in the logistic 
regression analysis for gastrointestinal symptoms, symptoms after some food and milk 
consumption. Statistically significant differences are presented in bold face.  
 
 
 
 
 
 
 
 
 
 
 
GI symptoms 
OR 
(95% CI) 
   Diarrhea 2.12 (0.58 – 7.76) 
   Flatulence 1.17 (0.62 – 2.21) 
   Nausea 1.04 (0.50 – 2.14) 
   Stomach pain 1.00 (0.68 – 1.46) 
   Regurgitation 0.98 (0.53 – 1.76) 
   Heartburn 0.82 (0.39 – 1.71) 
Symptoms after some food  
   Milk  1.95 (1.03 – 3.69) 
   Sour milk and kefir 1.61 (0.75 – 3.43) 
   Fried 1.61 (0.97 – 2.67) 
   Vegetables  1.25 (0.52 – 3.00) 
   Any other food 1.02 (0.59 – 1.75) 
   Fatty 0.68 (0.43 – 1.07) 
   Fruits 0.52 (0.20 – 1.31) 
Milk product consumption  
   Milk 1.51 (1.04 – 2.17) 
   Sour milk 1.10 (0.76 – 1.60) 
